ADUS:NSD-Addus HomeCare Corporation (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 128.89

Change

+0.03 (+0.02)%

Market Cap

USD 2.27B

Volume

0.04M

Analyst Target

USD 119.88
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

+0.87 (+0.65%)

USD 8.25B
OPCH Option Care Health Inc

-0.11 (-0.48%)

USD 4.00B
ACHC Acadia Healthcare Company Inc

+0.17 (+0.45%)

USD 3.78B
AMED Amedisys Inc

+0.08 (+0.09%)

USD 2.81B
LFST Lifestance Health Group Inc

+0.03 (+0.41%)

USD 2.74B
SGRY Surgery Partners Inc

-0.09 (-0.43%)

USD 2.59B
ASTH Astrana Health Inc

+0.01 (+0.03%)

USD 1.89B
AVAH Aveanna Healthcare Holdings In..

-0.06 (-1.34%)

USD 1.04B
HCSG Healthcare Services Group Inc

+0.39 (+3.51%)

USD 0.91B
CCRN Cross Country Healthcare Inc

+0.07 (+0.39%)

USD 0.58B

ETFs Containing ADUS

SBM 7.23 % 0.95 %

N/A

N/A
SMN ProShares UltraShort Basi.. 7.23 % 0.95 %

-0.16 (0.35%)

N/A
BASE-B:CA Evolve Global Materials &.. 5.10 % 0.00 %

+0.04 (+0.35%)

CAD 0.08B
JHMA 4.37 % 0.47 %

N/A

N/A
ABEQ Absolute Core Strategy ET.. 4.11 % 0.00 %

+0.11 (+0.35%)

USD 0.09B
XLPE:LSE Xtrackers LPX Private Equ.. 3.49 % 0.00 %

+43.00 (+0.35%)

N/A
IUMS:LSE iShares S&P 500 Materials.. 3.37 % 0.00 %

+0.06 (+0.35%)

USD 0.18B
IMSU:LSE iShares S&P 500 Materials.. 3.33 % 0.00 %

+3.25 (+0.35%)

N/A
UYM ProShares Ultra Basic Mat.. 2.97 % 0.95 %

+0.25 (+0.35%)

N/A
MXI iShares Global Materials .. 1.46 % 0.46 %

+0.29 (+0.35%)

N/A
VVAL:LSE 0.54 % 0.00 %

N/A

N/A
VCIT Vanguard Intermediate-Ter.. 0.10 % 0.07 %

-0.17 (0.35%)

USD 49.51B
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.00 %

+0.02 (+0.35%)

N/A
VCSH Vanguard Short-Term Corpo.. 0.08 % 0.07 %

-0.20 (0.35%)

USD 35.42B
VCLT Vanguard Long-Term Corpor.. 0.07 % 0.07 %

+0.01 (+0.35%)

USD 15.44B
BIV Vanguard Intermediate-Ter.. 0.05 % 0.07 %

-0.19 (0.35%)

N/A
BLV Vanguard Long-Term Bond I.. 0.04 % 0.07 %

-0.05 (0.35%)

N/A
BSV Vanguard Short-Term Bond .. 0.02 % 0.07 %

-0.20 (0.35%)

N/A
FMAT Fidelity® MSCI Materials.. 0.00 % 0.08 %

+0.28 (+0.35%)

N/A
SPVM Invesco S&P 500 Value wit.. 0.00 % 0.39 %

+0.43 (+0.35%)

USD 0.09B
VAW Vanguard Materials Index .. 0.00 % 0.10 %

+1.18 (+0.35%)

N/A
WMCR 0.00 % 0.50 %

N/A

N/A
SXLB:LSE SPDR S&P U.S. Materials S.. 0.00 % 0.00 %

+0.32 (+0.35%)

N/A
SCHI Schwab 5-10 Year Corporat.. 0.00 % 0.00 %

+0.05 (+0.35%)

USD 7.69B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 38.82% 93% A 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.82% 93% A 83% B
Trailing 12 Months  
Capital Gain 32.99% 93% A 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.99% 93% A 81% B-
Trailing 5 Years  
Capital Gain 35.56% 70% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.56% 70% C- 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 7.70% 56% F 57% F
Dividend Return 7.70% 56% F 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 24.27% 89% A- 71% C-
Risk Adjusted Return 31.73% 70% C- 63% D
Market Capitalization 2.27B 76% C+ 80% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.